People Background Check
Find People:

Guadalupe R Ruiz, Age 6014336 Pearmain St, Adelanto, CA 92301

Get Report
Known as:
Guadalupe Ruiz Reyes Guadalupe R Reyes Nuadalupe Ruiz Guadalup Ruiz Guadalu Ruiz
Related to:
Rolando Jose Reyes 54

Guadalupe Ruiz Phones & Addresses

Adelanto, CA

Springdale, AR

Baldwin Park, CA

Cleveland, TX

Miami, FL

Hempstead, NY

Baldwin Park, CA

Show more

Mentions for Guadalupe R Ruiz

Career records & work history

License Records

Guadalupe M Ruiz

Licenses:
License #: 38242 - Active
Category: Tow Truck Operator (Consent Tow)
Expiration Date: Mar 23, 2017

Guadalupe Ruiz resumes & CV records

Resumes

Guadalupe Ruiz Photo 42

Asistente General

Work:

Asistente General
Guadalupe Ruiz Photo 43

Guadalupe Ruiz

Guadalupe Ruiz Photo 44

Contractor

Work:
Opprett Bolig As
Contractor
Guadalupe Ruiz Photo 45

Guadalupe Gallardo Ruiz

Guadalupe Ruiz Photo 46

Guadalupe Beatriz Chimal Ruiz

Guadalupe Ruiz Photo 47

Sales

Work:
Tommy Hilfiger
Sales
Guadalupe Ruiz Photo 48

Guadalupe David Martinez Ruiz

Guadalupe Ruiz Photo 49

Guadalupe Ruiz - Covina, CA

Work:
Homox Medical Equipment - La Puente, CA Jan 2009 to Jul 2014
Front Desk Clerk
Education:
North West College - West Covina, CA 2008 to 2008
Certficate in Medical Billing Bell High School 2007
High School Diploma in Medical Billing Certification

Publications & IP owners

Us Patents

Methods For The Treatment Of Ocular And Neurodegenerative Conditions In A Mammal

US Patent:
2006026, Nov 23, 2006
Filed:
May 18, 2005
Appl. No.:
11/133922
Inventors:
Guadalupe Ruiz - Corona CA, US
Edwin Padillo - Orange CA, US
Elizabeth WoldeMussie - Laguna Niguel CA, US
International Classification:
A61K 31/517
US Classification:
514252170, 514266200
Abstract:
Method for the treatment of conditions including ocular and neurodegenerative conditions in a mammal using a composition which comprises an effective amount of an alpha 1 adrenoreceptor antagonist.

Intraocular Drug Delivery Systems

US Patent:
2008013, Jun 5, 2008
Filed:
Dec 1, 2006
Appl. No.:
11/565917
Inventors:
Michael R. Robinson - Irvine CA, US
Wendy M. Blanda - Tustin CA, US
Patrick M. Hughes - Aliso Viejo CA, US
Guadalupe Ruiz - Corona CA, US
Werhner C. Orilla - Anaheim CA, US
Scott M. Whitcup - Laguna Hills CA, US
Assignee:
ALLERGAN, INC. - Irvine CA
International Classification:
A61K 9/00
A61K 31/56
A61F 9/00
A61K 31/498
A61P 27/02
A61K 31/565
A61K 31/495
US Classification:
424428, 514182, 514249
Abstract:
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 10 days and one year or longer.

Method For Reducing Intraocular Pressure In The Mammalian Eye By Administration Of Chloride Channel Blockers

US Patent:
5559151, Sep 24, 1996
Filed:
Nov 30, 1994
Appl. No.:
8/346660
Inventors:
Joseph S. Adorante - Irvine CA
Elizabeth WoldeMussie - Laguna Niguel CA
Guadalupe Ruiz - Corona CA
Assignee:
Allergan - Waco TX
International Classification:
A61K 31195
US Classification:
514567
Abstract:
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chloride channel blocking activity. Examples of chloride channel blockers utilized in the pharmaceutical composition and method of treatment are: ##STR1## wherein R is hydrogen or a pharmaceutically-acceptable cation, e. g. an alkali or alkaline earth metal, or a quaternary amine; or R represents a ester-forming moiety, e. g. a lower alkyl radical, having up to six carbon atoms, that may be derived from a lower alkanol.

Method For Reducing Intraocular Pressure In The Mammalian Eye By Administration Of Calcium Chelators

US Patent:
5891911, Apr 6, 1999
Filed:
Jul 28, 1995
Appl. No.:
8/260648
Inventors:
Joseph S. Adorante - Irvine CA
Elizabeth WoldeMussie - Laguna Niguel CA
Guadalupe Ruiz - Corona CA
Assignee:
Allergan - Waco TX
International Classification:
A61K 3123
US Classification:
514532
Abstract:
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains as the active ingredient one or more compounds having calcium chelating activity. Examples of calcium chelating agents utilized in the pharmaceutical composition and method of treatment are: ##STR1## and lower alkyl and alkoxyalkyl esters thereof.

Method For Providing A Neuroprotective Effect To The Mammalian Eye By Administration Of Chloride Channel Blockers

US Patent:
5866605, Feb 2, 1999
Filed:
Dec 29, 1997
Appl. No.:
8/998912
Inventors:
Joseph S. Adorante - Irvine CA
Elizabeth WoldeMussie - Laguna Niguel CA
Guadalupe Ruiz - Corona CA
Assignee:
Allergan - Waco TX
International Classification:
A01K 31195
US Classification:
514567
Abstract:
Pharmaceutical compositions and a method are disclosed for providing neuroprotective effect to the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chloride channel blocking activity. Examples of chloride channel blockers utilized in the pharmaceutical composition and method of treatment are: ##STR1## wherein R is hydrogen or a pharmaceutically-acceptable cation, e. g. an alkali or alkaline earth metal, or a quaternary amine; or R represents a ester-forming moiety, e. g. a lower alkyl radical, having up to six carbon 20 atoms, that may be derived from a lower alkanol.

Method For Reducing Intraocular Pressure In The Mammalian Eye By Administration Of Potassium Channel Blockers

US Patent:
5925342, Jul 20, 1999
Filed:
Jul 9, 1997
Appl. No.:
8/891623
Inventors:
Joseph S. Adorante - Irvine CA
Elizabeth WoldeMussie - Laguna Niguel CA
Guadalupe Ruiz - Corona CA
Kara Kopper - Rancho Santa Margarita CA
Alison M. Moore - Santa Ana Heights CA
Assignee:
Allergan - Waco TX
International Classification:
A61K 3174
US Classification:
424 7804
Abstract:
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having potassium channel blocking activity. Examples of potassium channel blockers utilized in the pharmaceutical composition and method of treatment are quinine, tremogenic indole alkaloids, such as Penitrem A and paspalicine, and insect toxins such as charybdotoxin and iberiotoxin.

Method For Reducing Intraocular Pressure In The Mammalian Eye By Administration Of Chloride Channel Blockers

US Patent:
5705530, Jan 6, 1998
Filed:
Sep 23, 1996
Appl. No.:
8/716756
Inventors:
Joseph S. Adorante - Irvine CA
Elizabeth WoldeMussie - Laguna Niguel CA
Guadalupe Ruiz - Corona CA
Assignee:
Allergan - Waco TX
International Classification:
A61K 31195
US Classification:
514567
Abstract:
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chloride channel blocking activity. Examples of chloride channel blockers utilized in the pharmaceutical composition and method of treatment are: ##STR1## wherein R is hydrogen or a pharmaceutically-acceptable cation, e. g. an alkali or alkaline earth metal, or a quaternary amine; or R represents a ester-forming moiety, e. g. a lower alkyl radical, having up to six carbon atoms, that may be derived from a lower alkanol.

Method For Reducing Intraocular Pressure In The Mammalian Eye By Administration Of Potassium Channel Blockers

US Patent:
5573758, Nov 12, 1996
Filed:
Apr 28, 1995
Appl. No.:
8/431170
Inventors:
Joseph S. Adorante - Irvine CA
Elizabeth WoldeMussie - Laguna Niguel CA
Guadalupe Ruiz - Corona CA
Assignee:
Allergan - Waco TX
International Classification:
A61K 3174
US Classification:
424 7804
Abstract:
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having potassium channel blocking activity. Examples of potassium channel blockers utilized in the pharmaceutical composition and method of treatment are quinine, tremogenic indole alkaloids, such as Penitrem A and paspalicine, and insect toxins such as charybdotoxin and iberiotoxin.

Possible Relatives

Cyril Ruiz  D Ruiz  Dayana Ruiz  Daisy R Ruiz  Debbie A Ruiz  Damian E Ruiz  Deborah A Ruiz  Guadalupe Medellin  Guadalupe A Medina  Guadalupe M Medrano 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.